Amphion Innovationswww.amphionplc.com TICKER: AMP EXCHANGE: AIM
Amphion Innovations are company builders in the medical and technology sectors; the group uses a hands-on approach, providing management and seed financing, based on decades of experience in both the US and UK. Amphion has two specialized entities within its make-up, MSA Holding and DataTern, inc. MSA Holding is in place to replicate the Amphion model within the Gulf, presenting an opportunity for global investors to participate in the local life science and technology sectors through their investments. DataTern was established to maximise potential opportunities from commercialising IP prospects from their partner companies.
Unique process for commercialising IP Successful
20 year record; and NAV/share growth since IPO (2005) of 36% per annum ($), 28% (£)
Rigorous election process for investments, mitigating risk
Partner Companies performing well
Share price discount to reported NAV anomalous
- Positive trading update
- Strategic Gulf venture taps into rapidly growing market
- Myconostica: another UK addition to portfolio
- Significant realised gains on Beijing Med-Pharm
- 20 years of high NAV growth delivered by management
- Valued at a deep discount to peer group
Foreign buyers gorging on UK stocks
Document can be downloaded here: UK plc ‘going for a song’
Being a shareholder in a company that receives a juicy takeover offer is a marvellous feeling. Something that many fortunate investors have experienced over the past 3 years. Thanks to a spate of M&A bids by deep pocketed overseas buyers – partly triggered by the June 2016 Brexit result, which sent the £ tumbling and adversely affected the FTSE.
Consequently today, given this trend is unlikely to end anytime soon, we’ve highlighted 30 possible acquisition ideas in the attached research paper. Spilt equally between large and smallcap stocks – covering a broad selection of industries.
What’s more we believe most of these businesses are underpinned by strong fundamentals and substantial upside in the event of predatory interest.
According to Factset Mergerstat/BVR, the average bid premium paid for such deals between 2004-14 was 30% – with the figure trending upwards since the global financial crisis.
Happy investing. Published 27th August 2019